STOCK TITAN

Transactions of Managers and Closely Associated Persons

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Alvogen Lux Holdings S.ár.l., Alvotech's (ALVO) second-largest shareholder, has acquired 210,000 shares at ISK 1,277.38 per share. The transaction was reported through a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF). Alvogen Lux Holdings' ownership structure consists of CVC (40%), Aztiq (30%), and Temasek (20%) as its largest shareholders.

Alvogen Lux Holdings S.ár.l., il secondo azionista più grande di Alvotech (ALVO), ha acquistato 210.000 azioni al prezzo di ISK 1.277,38 per azione. L'operazione è stata comunicata tramite una dichiarazione alla Commission de Surveillance du Secteur Financier (CSSF) del Lussemburgo. La struttura proprietaria di Alvogen Lux Holdings è composta principalmente da CVC (40%), Aztiq (30%) e Temasek (20%).

Alvogen Lux Holdings S.ár.l., el segundo mayor accionista de Alvotech (ALVO), ha adquirido 210.000 acciones a ISK 1.277,38 por acción. La transacción fue reportada mediante una presentación ante la Comisión de Supervisión del Sector Financiero de Luxemburgo (CSSF). La estructura accionarial de Alvogen Lux Holdings está compuesta principalmente por CVC (40%), Aztiq (30%) y Temasek (20%).

Alvogen Lux Holdings S.ár.l.은 Alvotech (ALVO)의 두 번째로 큰 주주로서, 주당 ISK 1,277.38210,000주를 매입했습니다. 이 거래는 룩셈부르크 금융감독위원회(CSSF)에 신고되었습니다. Alvogen Lux Holdings의 소유 구조는 주요 주주로 CVC (40%), Aztiq (30%), Temasek (20%)로 구성되어 있습니다.

Alvogen Lux Holdings S.ár.l., le deuxième plus grand actionnaire d'Alvotech (ALVO), a acquis 210 000 actions au prix de ISK 1 277,38 par action. La transaction a été déclarée auprès de la Commission de Surveillance du Secteur Financier (CSSF) du Luxembourg. La structure de propriété d'Alvogen Lux Holdings est principalement composée de CVC (40%), Aztiq (30%) et Temasek (20%).

Alvogen Lux Holdings S.ár.l., der zweitgrößte Aktionär von Alvotech (ALVO), hat 210.000 Aktien zu einem Preis von ISK 1.277,38 pro Aktie erworben. Die Transaktion wurde durch eine Meldung bei der Luxemburger Finanzaufsichtsbehörde (CSSF) bekannt gegeben. Die Eigentümerstruktur von Alvogen Lux Holdings besteht hauptsächlich aus CVC (40%), Aztiq (30%) und Temasek (20%).

Positive
  • Significant insider buying of 210,000 shares demonstrates confidence in the company's future
  • Purchase by second-largest shareholder could signal stock is undervalued
Negative
  • None.

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 210,000 shares in Alvotech at ISK 1,277.38, by Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech. Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%) and Temasek (20%).

Attachment


FAQ

How many shares did Alvogen Lux Holdings purchase in Alvotech (ALVO) on May 13, 2025?

Alvogen Lux Holdings purchased 210,000 shares of Alvotech (ALVO) at ISK 1,277.38 per share.

Who are the largest shareholders of Alvogen Lux Holdings?

Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%), and Temasek (20%).

What is Alvogen Lux Holdings' position in Alvotech (ALVO)?

Alvogen Lux Holdings is the second-largest shareholder in Alvotech (ALVO).

What was the price per share paid by Alvogen Lux Holdings for ALVO stock?

Alvogen Lux Holdings paid ISK 1,277.38 per share for the Alvotech stock.
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Stock Data

2.51B
72.97M
64.88%
6.26%
0.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg